142 related articles for article (PubMed ID: 2940336)
1. Elevated postmortem monoamine oxidase B activity in the caudate nucleus in Huntington's disease compared to schizophrenics and controls.
Mann JJ; Kaplan RD; Bird ED
J Neural Transm; 1986; 65(3-4):277-83. PubMed ID: 2940336
[TBL] [Abstract][Full Text] [Related]
2. Brain monoamine oxidase activity in schizophrenics and controls.
Reveley MA; Glover V; Sandler M; Spokes EG
Arch Gen Psychiatry; 1981 Jun; 38(6):663-5. PubMed ID: 7247629
[TBL] [Abstract][Full Text] [Related]
3. [Monoamine oxidase activity in brain regions and organs of patients with Parkinson's disease and Huntington's disease and serum MAO activity of patients with Huntington's disease as compared with neurologically healthy individuals (author's transl)].
Schneider G; Oepen H; von Wedel HR
Arch Psychiatr Nervenkr (1970); 1981; 230(1):5-15. PubMed ID: 6455104
[TBL] [Abstract][Full Text] [Related]
4. Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gamma-glutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases.
Butterworth J; Yates CM; Reynolds GP
J Neurol Sci; 1985 Feb; 67(2):161-71. PubMed ID: 2858515
[TBL] [Abstract][Full Text] [Related]
5. Postmortem monoamine oxidase enzyme kinetics in the frontal cortex of suicide victims and controls.
Mann JJ; Stanley M
Acta Psychiatr Scand; 1984 Feb; 69(2):135-9. PubMed ID: 6702476
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen peroxide enhances the activity of monoamine oxidase type-B but not of type-A: a pilot study.
Konradi C; Riederer P; Youdim MB
J Neural Transm Suppl; 1986; 22():61-73. PubMed ID: 3097261
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of the isoenzymes MAO-A and MAO-B in the human basal ganglia and pons in Huntington's disease revealed by quantitative enzyme radioautography.
Richards G; Messer J; Waldvogel HJ; Gibbons HM; Dragunow M; Faull RL; Saura J
Brain Res; 2011 Jan; 1370():204-14. PubMed ID: 21075085
[TBL] [Abstract][Full Text] [Related]
8. Selective decreases in MAO-B activity in post-mortem brains from schizophrenic patients with type II syndrome.
Owen F; Crow TJ; Frith CD; Johnson JA; Johnstone EC; Lofthouse R; Owens DG; Poulter M
Br J Psychiatry; 1987 Oct; 151():514-9. PubMed ID: 3447667
[TBL] [Abstract][Full Text] [Related]
9. Brain and skeletal muscle monoamine oxidase activity in schizophrenia.
Meltzer HY; Jackman H; Arora RC
Schizophr Bull; 1980; 6(2):208-12. PubMed ID: 6103574
[TBL] [Abstract][Full Text] [Related]
10. Changes in nine enzyme markers for neurons, glia, and endothelial cells in agonal state and Huntington's disease caudate nucleus.
Butterworth J
J Neurochem; 1986 Aug; 47(2):583-7. PubMed ID: 2874190
[TBL] [Abstract][Full Text] [Related]
11. Platelet monoamine oxidase activity in subjects tested for Huntington's disease gene mutation.
Markianos M; Panas M; Kalfakis N; Vassilopoulos D
J Neural Transm (Vienna); 2004 Apr; 111(4):475-83. PubMed ID: 15057517
[TBL] [Abstract][Full Text] [Related]
12. Enzyme properties of monoamine oxidase in the frontal cortex and liver of the gerbil (Meriones unguiculatus).
Morioka D; Kanda Y; Izumi J; Hashimoto M; Inagaki M; Kiuchi Y; Oguchi K
Comp Biochem Physiol B; 1993; 105(3-4):585-90. PubMed ID: 8365114
[TBL] [Abstract][Full Text] [Related]
13. Biochemical abnormalities in Huntington's chorea brains.
Stahl WL; Swanson PD
Neurology; 1974 Sep; 24(9):813-9. PubMed ID: 4277376
[No Abstract] [Full Text] [Related]
14. Effect of aging on lazabemide binding, monoamine oxidase activity and monoamine metabolites in human frontal cortex.
Galva MD; Bondiolotti GP; Olasmaa M; Picotti GB
J Neural Transm Gen Sect; 1995; 101(1-3):83-94. PubMed ID: 8695059
[TBL] [Abstract][Full Text] [Related]
15. Monoamine oxidase-A and B activities in the cerebellum and frontal cortex of children and young adults with autism.
Gu F; Chauhan V; Chauhan A
J Neurosci Res; 2017 Oct; 95(10):1965-1972. PubMed ID: 28151561
[TBL] [Abstract][Full Text] [Related]
16. Monoamine oxidase-A and -B activities in the brain stem of schizophrenics and non-schizophrenic psychotics.
Fowler CJ; Carlsson A; Winblad B
J Neural Transm; 1981; 52(1-2):23-32. PubMed ID: 7288435
[TBL] [Abstract][Full Text] [Related]
17. Ontogenesis of monoamine oxidase-A and -B in the human brain frontal cortex.
Kornhuber J; Konradi C; Mack-Burkhardt F; Riederer P; Heinsen H; Beckmann H
Brain Res; 1989 Oct; 499(1):81-6. PubMed ID: 2804672
[TBL] [Abstract][Full Text] [Related]
18. Ornithine aminotransferase in Huntington's disease.
Wong PT; McGeer PL; Rossor M; McGeer EG
Brain Res; 1982 Jan; 231(2):466-71. PubMed ID: 6459816
[TBL] [Abstract][Full Text] [Related]
19. Platelet monoamine oxidase activity in patients with Huntington's disease.
Norman TR; Chiu E; French MA
Clin Exp Pharmacol Physiol; 1987 Jun; 14(6):547-50. PubMed ID: 2960476
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Excessive Monoamine Oxidase A/B Activity Protects Against Stress-induced Neuronal Death in Huntington Disease.
Ooi J; Hayden MR; Pouladi MA
Mol Neurobiol; 2015 Dec; 52(3):1850-1861. PubMed ID: 25398695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
